CD38 and rheumatoid arthritis: Similarly, treatment with TAK-079 prevented arthritis development accompanied by a decrease of NK cells, T cells and B cells in blood of cynomolgus monkeys (118) These data support a pathogenic role for CD38 in RA via humoral and cellular responses.